Non-leukodepleted group | Leukodepleted group | |
---|---|---|
n = 10 | n = 10 | |
Age, years | 70 (65–72) | 74 (64–79) |
Sex, male; female | 5; 5 | 7; 3 |
SAPS II on admission | 37 (28–74) | 41 (35–47) |
ICU days before enrollment | 9 (8–12) | 9 (4–29) |
Sepsis, number | 2 | 5 |
Severe sepsis, number | 3 | 2 |
Septic shock, number | 5 | 3 |
Source of infection, number | ||
Lung | 4 | 3 |
Abdomen | 1 | 3 |
Urinary tract | 2 | 1 |
Miscellaneous | 3 | 3 |
Adrenergic dosea | ||
Norepinephrine | 5; 0.047 (0.015–0.370) | 3; 0.155 (0.050–0.260) |
Dobutamine | 1; 2.074 (2.074–2.074) | 1; 2.31 (2.31–2.31) |